Malaria has been a major parasitic disease in tropical and subtropical regions and is
estimated to kill between one and two million people (mainly children) every year. Novel anti …

The resistance of malaria parasites to existing drugs carries on growing and progressively
limiting our ability to manage this severe disease and finally lead to a massive global health …

Malaria has emerged as a major health problem worldwide after the appearance of resistant
strains of Plasmodium falciparum to the most of antimalarial drugs. The development of …

Malaria is a global health problem that needs attention of drug discovery scientists to
investigate novel compounds with high drug efficacy, safety and low cost to counter the …

The upward extend of malaria collectively with the emergence of resistance against
predictable drugs has put enormous pressure on public health systems to introduce new …

Background: Despite the successes achieved recently in the treatment of various infectious
diseases, the morbidity and mortality associated with malaria remain major burdens …

Natural products remain a rich source of novel molecular scaffolds for novel antimalarial
agents in the fight against malaria. This has been well demonstrated in the case of quinine …

Malaria is a major public health problem all over the world, particularly in tropical and
subtropical countries due to the development of resistance and most deadly infection is …

Infections caused by protozoan parasites continue to be a significant cause of morbidity and
mortality across the globe, with malaria and leishmaniasis forming the fulcrum of these …

Background Developing resistance towards existing anti-malarial therapies emphasize the
urgent need for new therapeutic options. Additionally, many malaria drugs in use today have …